TCM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve Notice is hereby given that a Meeting of the Board of Directors would be held on Monday, 27th May 2024 at 10:30 A.M. at the Registered Office of the Company inter alia, consider and approve: - 1. The Consolidated and Standalone Audited Financial Statements of the Company for the quarter and year ended 31st March 2024. 2. Any other matter with the permission of the Chair. Further, in continuation of our intimation dated 28th March 2024 regarding closure of Trading Window, we would like to re-iterate that the trading window shall re-open after 48 hours from the declaration of the financial results. We request you to take the information on record.

pdf

TCM Ltd.

13 May 2024

42.92

-5.13%

Company Update

TCM LTD. - 524156 - Corporate Announcement- Entering Into MOU With Biogenix Inc. Pvt. Ltd For …

BSE India

In accordance with the provisions of the SEBI(LODR) Regulations 2015, we are pleased to inform our shareholders that your Company has entered into a MoU, DT.13th May 2024 with M/s Biogenix Inc. Pvt. Ltd, Lucknow for contract manufacture of several reagents used in diagnostic laboratories for various test s on behalf of TCM Ltd. The details of MoU are as per attachment.

pdf

TCM Ltd.

13 May 2024

42.92

-5.13%

Corp. Note

TCM LTD. - 524156 - Board Meeting Outcome for Outcome Of The Board Meeting Held On …

BSE India

The Board of Directors of the Company in its meeting held on Monday, 13th May 2024, on a shorter notice, has considered and approved the following business:- 1. Read and Confirmed the Minutes of the previous Board Meetings held on 12th February 2024 2. Took note of the Declaration received from the Directors in Form MBP-1 pursuant to Section 184(1) of the Companies Act, 2013 read with Rule 9(2) of the Companies (Meeting of Board and its Powers) Rules, 2014. 3. Took note of the Declaration furnished by Directors in Form DIR-8 pursuant to Section 164(2) of the Companies Act, 2013. 4. Discussed and approved to enter into a Memorandum of Understanding with M/s Biogenix Inc Pvt Ltd, Lucknow for contract manufacture of various reagents which are used in diagnostic laboratories for various tests, on behalf of our company. The meeting commenced at 12.30 P.M. and concluded at 01:15 P.M.

pdf

TCM Ltd.

27 Apr 2024

42.92

-5.13%

Company Update

TCM LTD. - 524156 - Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015 For …

BSE India

Pursuant to Regulation 40(9) & (10) of the SEBI(LODR) Regulations 2015, please find attached the Compliance Certificate from our PCS for the financial year ended 31st March 2024.

pdf

TCM Ltd.

18 Apr 2024

42.92

-5.13%

Corp. Note

TCM LTD. - 524156 - Format of the Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTCM LTD. 2CIN NO.L24299KL1943PLC001192 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 25.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Gokul V Shenoy Designation: Company Secretary and Compliance Officer EmailId: cs@tcmlimited.in Name of the Chief Financial Officer: M P Mohanan Designation: Chief Financial Officer EmailId: mpmohan@tcmlimited.in Date: 18/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

TCM Ltd.

09 Apr 2024

42.92

-5.13%

Company Update

TCM LTD. - 524156 - Compliances-Compliance Certificate For The Period Ended 31St March 2024

BSE India

In compliance with the requirements under Regulation 7(3) of SEBI(LODR) Regulations 2015, we are enclosing herewith Compliance Certificate for the financial year ended 31st March 2024 duly signed by the authorized representative of the Registrar and Share Transfer Agent- Cameo Corporate Services Ltd and the Compliance Officer/ Company Secretary of the Company. This is for the information and records of the Exchange.

pdf

TCM Ltd.

08 Apr 2024

42.92

-5.13%

Company Update

TCM LTD. - 524156 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are hereby enclosing a Confirmation Certificate under Regulation 74(5) of SEBI(DP)Regulations 2018 for the quarter ending 31st March 2024 received from our RTA, M/s Cameo Corporate Services Ltd. Kindly take the same on record. Thanking you

pdf

TCM Ltd.

06 Apr 2024

42.92

-5.13%

AGM

TCM LTD. - 524156 - REVISED Proceedings Of 79Th Annual General Meeting Of The Company Held …

BSE India

We hereby attach the REVISED proceedings of the AGM held on 29th September 2023, with our explanation for disclosure to the exchange beyond 12 hours from the conclusion of the AGM. Therefore, we request you to kindly accept our delayed submission. Thank you

pdf

TCM Ltd.

28 Mar 2024

42.92

-5.13%

SAST

TCM LTD. - 524156 - Closure of Trading Window

BSE India

In compliance of SEBI(PIT) Regulations 2015, read with amendments thereto and further clarification given by BSE vide its letter dated 02nd April 2019 vide Ref No. LIST/COMP/01/2019-20, regarding trading restriction period for dealing in the securities of the Company shall remain closed from Monday, 01st April 2024 till48 hours after the announcement/ declaration of audited financial results for the quarter and year ended 31st March 2024 (both days inclusive). The trading window will open 48 hours after the announcement/ declaration of the audited financial results for the quarter and year ended 31st March 2024 is made by the Company to the stock exchange. The date of Board Meeting shall be intimated to you separately. We request you to kindly take note of the above.

pdf

Is TCM Ltd. worth buying?

21 Votes:

Buy 71.43%

Sell 14.29%

Hold 14.29%